Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_assertion type Assertion NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_head.
- NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_assertion description "[The objective of the study was to evaluate the prognostic effect of p53, p27, and C-MYC on clinicopathological features, recurrent disease, and disease-free survival (DFS) of 131 patients with ovarian cancer in International Federation of Gynecology and Obstetrics (FIGO) stages I-II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_provenance.
- NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_assertion evidence source_evidence_literature NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_provenance.
- NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_assertion SIO_000772 21270607 NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_provenance.
- NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_assertion wasDerivedFrom befree-2016 NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_provenance.
- NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_assertion wasGeneratedBy ECO_0000203 NP868092.RAnEZ3qj2RKiUIGP7aGm0ZNcSTkA4Zk3tzozqjwDhWk6s130_provenance.